Joel Greenblatt Adaptive Biotechnologies Corp Transaction History

Gotham Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$6.19 - $8.78 $186,999 - $265,243	-30,210 Reduced 65.27%	16,073 $107,000
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $114,004 - $147,767	14,616 Added 46.16%	46,283 $408,000
Q4 2022 Feb 14, 2023	SELL	$6.26 - $9.34 $124,048 - $185,081	-19,816 Reduced 38.49%	31,667 $241,000
Q3 2022 Nov 14, 2022	SELL	$6.5 - $12.67 $4,699 - $9,160	-723 Reduced 1.38%	51,483 $367,000
Q2 2022 Aug 15, 2022	BUY	$6.4 - $14.73 $334,118 - $768,994	52,206 New	52,206 $422,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.